Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Bone Neoplasms × olaparib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 23 Breast Neoplasms 13 Neoplasms 9 Triple Negative Breast Neoplasms 6 Prostatic Neoplasms 6 Sarcoma 5 Pancreatic Neoplasms 5 Fanconi Anemia, Complementation Group D1 5 Endometrial Neoplasms 5 Small Cell Lung Carcinoma 4 Neoplasm Metastasis 4 Colorectal Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Recurrence 3 Fallopian Tube Neoplasms 3 Stomach Neoplasms 2 Rhabdomyosarcoma 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Metastatic Castration-resistant Prostate Cancer 2 Glioma 2 Central Nervous System Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma 2 Advanced Solid Tumours 2 Advanced Solid Tumors 2 Wilms Tumor 1 Urinary Bladder Neoplasms 1 Triple Negative Metastatic Breast Cancer 1 Solid Tumor 1 Smoking 1

Interventions

Ibandronic Acid 5 pembrolizumab 2 Sunitinib 2 Radiotherapy, Intensity-Modulated 2 Nivolumab 2 Methods 2 Interviews as Topic 2 Injections 2 Denosumab 2 selinexor 1 ridaforolimus 1 radium Ra 223 dichloride 1 pegfilgrastim 1 olaparib 1 montanide ISA 51 1 lentiviral minigene vaccine of COVID-19 coronavirus 1 endostar protein 1 cc-486 1 angiotensin I (1-7) 1 Zoledronic Acid 1 Vincristine 1 Transplantation, Homologous 1 Transplantation, Autologous 1 Transcranial Direct Current Stimulation 1 Trabectedin 1 Tomography, Spiral Computed 1 TES 1 Surveys and Questionnaires 1 Standard of Care 1 Radiomics 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02398058 2021-04-14

TOMAS

Italian Sarcoma Group

Phase 1 Completed

Bone Neoplasms, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡